Katherine Araque

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study

Rosario Pivonello, Rosario Pivonello, Giorgio Arnaldi, Richard J Auchus et autres

it, es, us, ro, de, bg, nl, pl (code pays fourni par la source)

Corrigendum to “Medical treatment of hypercortisolism with relacorilant: Final results of the phase 3 GRACE study” [American Heart Journal 278S (2024) Pages 10-11]

Rosario Pivonello, Giorgio Arnaldi, Richard J. Auchus, Corin Badiu et autres

MON-088 Effects Of Relacorilant On Pituitary Tumor Volume In Patients With Cushing Disease: Results From The Phase 3 Grace Study

Georgiana Dobri, Giorgio Arnaldi, Richard J. Auchus, Corin Badiu et autres

us, ar, ro, nl, at, it, es, de (code pays fourni par la source)

OR12-05 Effects of Relacorilant on Body Weight and Body Composition in Patients With Endogenous Hypercortisolism in the Phase 3 GRACE and GRADIENT Studies

Oksana Hamidi, Richard J. Auchus, Robert S. Busch, Honey E. East et autres

us, nl, pl, by, it, de (code pays fourni par la source)

SUN-463 Efficacy and Safety of Relacorilant in Individuals With Adrenal Hypercortisolism: Results From the Phase 3 GRACE and GRADIENT Studies

Ulrich Dischinger, Amer Al‐Karadsheh, Corin Badiu, Filippo Ceccato et autres

de, us, ro, it, pl, at, es, il (code pays fourni par la source)

Impact of Relacorilant on Blood Pressure and Antihypertensive Medication Burden in Patients With Hypercortisolism and Hypertension: Results From the GRACE Study

Serge Jabbour, Giorgio Arnaldi, Richard J. Auchus, Corin Badiu et autres

us, it, ro, de, es (code pays fourni par la source)

Relacorilant Improved Blood Pressure and Maintained Other Cardiometabolic Improvements in Long-term Study in Patients With Endogenous Hypercortisolism (Cushing Syndrome)

Richard J. Auchus, Aleksandra Gilis‐Januszewska, Corin Badiu, Aurelian-Emil Ranetti et autres

us, pl, ro, at, it (code pays fourni par la source)

Medical treatment of hypercortisolism with relacorilant: Final results of the phase 3 GRACE study

Rosario Pivonello, Giorgio Arnaldi, Richard J. Auchus, Corin Badiu et autres

Relacorilant improved blood pressure and maintained other cardiometabolic improvements in long-term study in patients with endogenous hypercortisolism (Cushing syndrome)

Corin Badiu, Richard J. Auchus, Irina Bancos, Ulrich Dischinger et autres

Medical Treatment of Hypercortisolism with Relacorilant: Final Results of the Phase 3 GRACE Study

Rosario Pivonello, Giorgio Arnaldi, J. Richard Auchus, Corin Badiu et autres

it, us, ro, de, bg, nl, es, pl (code pays fourni par la source)

Abstract #1885059 Open-Label Extension Study Evaluating the Safety and Efficacy of Long-Term Use of Relacorilant in Patients With Endogenous Hypercortisolism (Cushing Syndrome): Results From the First Interim Analysis

Tina K. Schlafly, Corin Badiu, Richard J. Auchus, Irina Bancos et autres

us, ro, de, at, es, it, il (code pays fourni par la source)

Abstract #1909602 Relacorilant Maintained Hypertension Improvement in Long-Term Follow-Up of Patients With Endogenous Hypercortisolism (Cushing Syndrome)

Valerie Hilliard, Aleksandra Gilis‐Januszewska, Corin Badiu, Aurelian-Emil Ranetti et autres

us, pl, ro, at, it (code pays fourni par la source)